A Genotype-Phenotype Urothelial Cancer Study
[Protocol 09-025] |
Bajorin, Dean, MD |
A Phase I Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer
[Protocol 09-035] |
Cox, Brett, MD |
A Phase I Dose-Escalation Study of Image-Guided Radiation Therapy for Bladder Cancer Patients Undergoing Radiotherapy and Concurrent Gemcitabine Chemotherapy
[Protocol 10-031] |
Kollmeier, Marisa, MD |
A Phase I Study of AGS-16M8F in Patients with Advanced Renal Cell Carcinoma
[Protocol 10-075] |
Molina, Ana Maria, MD |
A Phase I Study of ASG-5ME Therapy Patients with Advanced Prostate Cancer
[Protocol 10-138] |
Morris, Michael, MD |
A Phase I Study of PSMA ADC in Patients with Progressive Castration-Resistant Metastatic Prostate Cancer
[Protocol 11-099] |
Slovin, Susan, MD, PhD |
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer
[Protocol 05-031] |
Larson, Steven, MD |
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer
[Protocol 10-106] |
Bajorin, Dean, MD |
A Phase I/II Study of ARN-509 in Patients with Progressive Metastatic Castration-Resistant Prostate Cancer
[Protocol 09-002] |
Rathkopf, Dana, MD |
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] |
Keohan, Mary, MD |
A Phase I/II Study of Everolimus and Intravesical Gemcitabine in BCG-Refractory Primary or Secondary Non-Muscle-Invasive Bladder Cancer
[Protocol 10-165] |
Dalbagni, Guido, MD |
A Phase I/II Trial of IMC-A12 plus Temsirolimus in Metastatic Castration-Resistant Prostate Cancer
[Protocol 09-117] |
Rathkopf, Dana, MD |
A Phase I/IIa Study of Alpharadin® Plus Docetaxel in Patients with Bone Metastases from Castration-Resistant Prostate Cancer
[Protocol 10-086] |
Morris, Michael, MD |
A Phase IA/IB Study of EZN-4176 in Patients with Castration-Resistant Prostate Cancer
[Protocol 11-010] |
Danila, Daniel, MD |
A Phase Ib Study of MDX-1106 in Patients with Selected Advanced or Recurrent Malignancies
[Protocol 09-012] |
Carvajal, Richard, MD |
A Phase IB/II Study of BEZ235 in Patients with Advanced Renal Cell Carcinoma
[Protocol 11-080] |
Molina, Ana Maria, MD |
A Phase IB/II study of E7080 plus Everolimus in Patients with Unresectable Advanced/Metastatic Renal Cell Carcinoma
[Protocol 10-084] |
Molina, Ana Maria, MD |
A Phase II Study of DN24-02 as Adjuvant Therapy in Patients with High-Risk HER2-positive Urothelial Cancers
[Protocol 11-163] |
Bajorin, Dean, MD |
A Phase II Study of Flavopiridol Plus Oxaliplatin with or without 5-FU and Leucovorin for Relapsed or Refractory Germ-Cell Tumors
[Protocol 09-034] |
Feldman, Darren, MD |
A Phase II Study of GDC-0980 versus Everolimus in Patients with Progressive Metastatic Renal Cell Carcinoma
[Protocol 11-178] |
Motzer, Robert, MD |
A Phase II Study of Short-Course Androgen Deprivation (Hormonal) Therapy with or without Bevacizumab for PSA Recurrence of Prostate Cancer after Definitive Local Therapy
[Protocol 09-123] |
Slovin, Susan, MD, PhD |
A Phase II Study of Tesetaxel in Patients with Previously Treated Metastatic Transitional Cell Urothelial Cancer
[Protocol 10-135] |
Bajorin, Dean, MD |
A Phase II Study of Tesetaxel in Patients with Progressive, Castration-Resistant Prostate Cancer
[Protocol 11-012] |
Morris, Michael, MD |
A Phase II Study of TKI258 in Patients with Advanced Urothelial Carcinoma
[Protocol 10-058] |
Bajorin, Dean, MD |
A Phase II Trial of Everolimus and Bevacizumab in Advanced Non-Clear Cell Renal Cell Cancer
[Protocol 10-226] |
Molina, Ana Maria, MD |
A Phase III Study of Mitomycin C versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer
[Protocol 09-118] |
Dalbagni, Guido, MD |
A Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
[Protocol 07-041] |
Eastham, James, MD |
A Phase III Study of Pazopanib as Adjuvant Therapy for Patients with Localized or Locally Advanced Renal Cell Carcinoma Following Nephrectomy
[Protocol 10-162] |
Motzer, Robert, MD |
A Phase III Study of ProstAtakTM as an Adjuvant to Up-front Radiation Therapy for Localized Prostate Cancer
[Protocol 11-172] |
Zelefsky, Michael, MD |
A Phase III Trial of Short-Term Androgen Deprivation with Pelvic Lymph Node or Prostate Bed-Only Radiotherapy in Prostate Cancer Patients with a Rising PSA after Radical Prostatectomy
[Protocol 09-102] |
Zelefsky, Michael, MD |
A Pilot Study of High Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer
[Protocol 07-120] |
Yamada, Yoshiya, MD |
A Prospective Study of Quality of Life in Patients Undergoing Pelvic Exenteration
[Protocol 05-001] |
Chi, Dennis, MD |
A Prospective Study of Quality of Life in Patients with Invasive Bladder Cancer
[Protocol 08-076] |
Bochner, Bernard, MD |
A Prospective, Randomized Trial Comparing Robotic and Open Radical Cystectomy
[Protocol 10-016] |
Laudone, Vincent, MD |
A Randomized Trial of Pharmacological Penile Rehabilitation in the Preservation of
Erectile Function Following Bilateral Nerve-Sparing Radical Prostatectomy
[Protocol 09-005] |
Mulhall, John, MD |
A Study of XL184 in Men with Advanced Prostate Cancer
[Protocol 10-209] |
Rathkopf, Dana, MD |
Adoptive Transfer of Autologous T Cells Targeted to Prostate-Specific Membrane Antigen for the Treatment Of Castrate Metastatic Prostate Cancer
[Protocol 09-036] |
Slovin, Susan, MD, PhD |
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051] |
Offit, Kenneth, MD |
Evaluating the Causes of Cancer in Young Patients
[Protocol 09-068] |
Stadler, Zsofia, MD |
Evaluation of Freezing Kidney Cancer Followed by Confirmation with Biopsy or Resection
[Protocol 09-108] |
Solomon, Stephen, MD |
Functions of Affect in Treatment Decisions of Rising PSA Patients
[Protocol 10-070] |
Nelson, Christian, PhD |
Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
[Protocol 11-112] |
Kissane, David, MD |
Longitudinal Assessment of Health-Related Quality of Life in Men with Localized Prostate Cancer
[Protocol 02-042] |
Scardino, Peter, MD |
Phase I Study of DSTP3086S in Patients with Metastatic Castration-Resistant Prostate Cancer
[Protocol 11-016] |
Danila, Daniel, MD |
Phase II Study Assessing the Potential for Reduced Toxicity Using Focal Brachytherapy in Low-Risk Prostate Cancer
[Protocol 11-056] |
Zelefsky, Michael, MD |
Phase II Study of Gemcitabine and Cisplatin before Surgery in Patients with High-Grade Upper Tract Urothelial Carcinoma
[Protocol 10-208] |
Coleman, Jonathan, MD |
Phase II Trial of Paclitaxel, Ifosfamide, and Cisplatin in Patients with Previously Untreated Advanced Germ Cell Tumors
[Protocol 07-044] |
Feldman, Darren, MD |
Pilot Study of a Geriatric-Specific Psychoeducational Intervention for Elderly Cancer Patients
[Protocol 09-116] |
Roth, Andrew, MD |
PREVAIL: A Phase III Study of MDV3100 in Patients with Progressive Metastatic Prostate Cancer Who Have Had Hormonal Therapy
[Protocol 10-195] |
Rathkopf, Dana, MD |
Prospective Assessment of Clinical and Quality of Life Outcomes After Open or Laparoscopic Radical Prostatectomy
[Protocol 04-094] |
Eastham, James, MD |
